Charcot Foot: Investigations

[1]  L. Lavery,et al.  The value of inflammatory markers to diagnose and monitor diabetic foot osteomyelitis , 2017, International wound journal.

[2]  M. Edmonds,et al.  Acute Charcot neuro‐osteoarthropathy , 2016, Diabetes/metabolism research and reviews.

[3]  M. Edmonds,et al.  Inflammatory and bone turnover markers in a cross‐sectional and prospective study of acute Charcot osteoarthropathy , 2015, Diabetic medicine : a journal of the British Diabetic Association.

[4]  E. Chantelau,et al.  Is the Eichenholtz classification still valid for the diabetic Charcot foot? , 2014, Swiss medical weekly.

[5]  E. Brocco,et al.  Ischemic Charcot foot: different disease with different treatment? , 2013, The Journal of cardiovascular surgery.

[6]  E. Chantelau,et al.  The acute diabetic Charcot foot managed on the basis of magnetic resonance imaging--a review of 71 cases. , 2013, Swiss medical weekly.

[7]  D. Towler,et al.  Diabetic foot osteomyelitis: bone markers and treatment outcomes. , 2012, Diabetes research and clinical practice.

[8]  E. Chantelau.  Start treatment early to avoid Charcot foot deformity , 2012, BMJ : British Medical Journal.

[9]  Lee C. Rogers,et al.  The Charcot Foot in Diabetes , 2011, Diabetes Care.

[10]  E. Chantelau.  The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[11]  A. Foster,et al.  Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[12]  J. Adams,et al.  Osteopenia, Neurological Dysfunction, and the Development of Charcot Neuroarthropathy , 1995, Diabetes Care.

[13]  S. Meyer.  The Pathogenesis of Diabetic Charcot Joints. , 1992 .